Are Insights leaders seeing real commercial value from AI ad...
Day One Strategy’s second annual AI in Pharma State of Play report addresses the challenges Pharma Insights teams are facing as AI adoption continues.
Rhapsido is first drug cleared for chronic hives disorder SD
Novartis' oral BTK inhibitor Rhapsido has had its label expanded in the US to include a second indication that causes chronic hives.
MSD ordered to pull injectable Keytruda from sale in Europe
MSD has been rocked by a court judgment ordering it to stop making and selling subcutaneous Keytruda in eight European markets.
European biotech leaders say optimism is returning
Senior figures in European biopharma think dealmaking and M&A will increase in the region, and could be helped by US policy uncertainties.
Latest News
Views & Analysis
Deep Dive
White Papers & Webinar
Podcasts & Video
Partner Content
Europe's Largest Gathering for ADC Innovation
Taking place in London from 8-11 March 2027, the 17th World ADC London returns as Europe's largest annual gathering dedicated to the ADC community
PharmaMarketing Summit 2027 to Convene America's Top Pharmac...
Elite industry leaders will gather to address AI-driven engagement, launch excellence, and the future of market access at an exclusive, invitation-only event
3rd Annual Personalized Cancer Vaccine Summit 2026 | Decembe...
The 3rd Annual Personalized Cancer Vaccine Summit brings together leaders from across companies to share data-driven insights
CPHI Milan 2026 showcases new Sustainability Summit
The first-time event will bring delegates together to discuss sustainability challenges
Pharmaceutical thought leaders gather at CPHI Milan 2026
Industry leaders will address topics such as manufacturing transformation and future therapies